This partnership aims to transform cell therapy workflows with Chain of Identity and Chain of Custody compliance standards.
ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback